Skip to main content

Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.

Publication ,  Journal Article
Taketomi, T; Szlam, F; Levy, JH; Tanaka, KA
Published in: Blood Coagul Fibrinolysis
January 2008

Duke Scholars

Published In

Blood Coagul Fibrinolysis

DOI

ISSN

0957-5235

Publication Date

January 2008

Volume

19

Issue

1

Start / End Page

106 / 108

Location

England

Related Subject Headings

  • Warfarin
  • Thrombin
  • Thrombelastography
  • Recombinant Proteins
  • Plasma
  • Humans
  • Fibrinolysis
  • Factor VIIa
  • Drug Interactions
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Taketomi, T., Szlam, F., Levy, J. H., & Tanaka, K. A. (2008). Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII. Blood Coagul Fibrinolysis, 19(1), 106–108. https://doi.org/10.1097/MBC.0b013e3282f185c9
Taketomi, Taro, Fania Szlam, Jerrold H. Levy, and Kenichi A. Tanaka. “Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.Blood Coagul Fibrinolysis 19, no. 1 (January 2008): 106–8. https://doi.org/10.1097/MBC.0b013e3282f185c9.
Taketomi, Taro, et al. “Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.Blood Coagul Fibrinolysis, vol. 19, no. 1, Jan. 2008, pp. 106–08. Pubmed, doi:10.1097/MBC.0b013e3282f185c9.

Published In

Blood Coagul Fibrinolysis

DOI

ISSN

0957-5235

Publication Date

January 2008

Volume

19

Issue

1

Start / End Page

106 / 108

Location

England

Related Subject Headings

  • Warfarin
  • Thrombin
  • Thrombelastography
  • Recombinant Proteins
  • Plasma
  • Humans
  • Fibrinolysis
  • Factor VIIa
  • Drug Interactions
  • Cardiovascular System & Hematology